Human papillomavirus and immunosuppression
- PMID: 24643184
- DOI: 10.1159/000357907
Human papillomavirus and immunosuppression
Abstract
Chronic immunosuppression for various reasons is an important risk factor for persistent infections with human papillomaviruses (HPV) and HPV-associated disease. Anogenital cancers and their precursor lesions play an important role in modern HIV medicine. Anal intraepithelial neoplasia and anal cancer are especially prevalent in HIV-positive men who have sex with men, and experts have advocated screening similarly to cervical cancer screening for this high-risk group. HPV-induced skin warts are a frequent problem of organ transplant recipients (OTRs) and a severe manifestation (generalized verrucosis) of certain primary immunodeficiencies. HIV-positive individuals are very often affected by genital warts (condylomata acuminata). Iatrogenic immunosuppression in OTRs allows more active replication of the commensal β-papillomavirus spectrum in the entire skin. A high viral DNA load in plucked eyebrow hairs was shown to imply a significant risk for the development of cutaneous squamous cell carcinoma. This may explain the up to 250-fold increased risk of OTRs to develop precancerous actinic keratoses and skin cancer.
© 2014 S. Karger AG, Basel.
Similar articles
-
The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.Cancer Res. 2003 Nov 1;63(21):7515-9. Cancer Res. 2003. PMID: 14612553
-
Genitoanal human papillomavirus infection and associated neoplasias.Curr Probl Dermatol. 2014;45:98-122. doi: 10.1159/000358423. Epub 2014 Mar 13. Curr Probl Dermatol. 2014. PMID: 24643181
-
The epidemiology of human papillomaviruses.Curr Probl Dermatol. 2014;45:75-91. doi: 10.1159/000358370. Epub 2014 Mar 13. Curr Probl Dermatol. 2014. PMID: 24643179 Review.
-
High viral load of human wart-associated papillomaviruses (PV) but not beta-PV in cutaneous warts independent of immunosuppression.Br J Dermatol. 2009 Sep;161(3):528-35. doi: 10.1111/j.1365-2133.2009.09297.x. Epub 2009 Jun 9. Br J Dermatol. 2009. PMID: 19519829
-
Human papillomavirus infection and skin cancer risk in organ transplant recipients.J Investig Dermatol Symp Proc. 2001 Dec;6(3):207-11. doi: 10.1046/j.0022-202x.2001.00048.x. J Investig Dermatol Symp Proc. 2001. PMID: 11924829 Review.
Cited by
-
Human Papillomavirus-induced Cutaneous and Mucosal Lesions in a Patient with Rothmund-Thomson Syndrome.Acta Derm Venereol. 2020 Aug 19;100(15):adv00252. doi: 10.2340/00015555-3596. Acta Derm Venereol. 2020. PMID: 32725251 Free PMC article. No abstract available.
-
Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk.Front Immunol. 2023 Mar 7;14:1112513. doi: 10.3389/fimmu.2023.1112513. eCollection 2023. Front Immunol. 2023. PMID: 36960048 Free PMC article. Review.
-
Biomarkers in Anal Cancer: Current Status in Diagnosis, Disease Progression and Therapeutic Strategies.Biomedicines. 2022 Aug 20;10(8):2029. doi: 10.3390/biomedicines10082029. Biomedicines. 2022. PMID: 36009576 Free PMC article. Review.
-
Localization of Felis catus Papillomavirus Type 2 E6 and E7 RNA in Feline Cutaneous Squamous Cell Carcinoma.Vet Pathol. 2018 May;55(3):409-416. doi: 10.1177/0300985817750456. Epub 2018 Jan 17. Vet Pathol. 2018. PMID: 29343198 Free PMC article.
-
Sexually transmitted human papillomavirus and related sequelae.Clin Microbiol Rev. 2025 Mar 13;38(1):e0008523. doi: 10.1128/cmr.00085-23. Epub 2025 Feb 14. Clin Microbiol Rev. 2025. PMID: 39950806 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical